Skip to content
drillr.ai
Sign up

CRSP

CRISPR Therapeutics AG

NASDAQ · Healthcare · Biotechnology · CH

$51.78
+3.57%
Ask drillr
0
Insider buys (3m)
7
Insider sells (3m)
-$4.9M
Net value (3m)
-2.8%
Price return (3m)
Form 4 filings
DateInsiderActivitySharesPrice
Oct 28, 2026Patel Naimish · officer: Chief Medical OfficerA-Award12,000$0.00
Oct 28, 2026Kulkarni Samarth · director, officer: Chief Executive OfficerA-Award57,500$49
Oct 28, 2026Patel Naimish · officer: Chief Medical OfficerA-Award24,000$49
Oct 28, 2026Silver Andrew Jacob · officer: Chief Financial OfficerA-Award18,000$49
Oct 28, 2026Kulkarni Samarth · director, officer: Chief Executive OfficerA-Award28,750$0.00
Oct 28, 2026KASINGER JAMES R. · officer: General Counsel and SecretaryA-Award9,000$0.00
Oct 28, 2026KASINGER JAMES R. · officer: General Counsel and SecretaryA-Award18,000$49
Oct 28, 2026Silver Andrew Jacob · officer: Chief Financial OfficerA-Award9,000$0.00
Oct 21, 2026Silver Andrew Jacob · officer: Chief Financial OfficerA-Award25,000$0.00
Oct 20, 2026Kulkarni Samarth · director, officer: Chief Executive OfficerSale47,837$50
Oct 20, 2026Kulkarni Samarth · director, officer: Chief Executive OfficerM-Exempt100,000$0.00
Oct 16, 2026George Simeon · directorSale14,514$50
Oct 16, 2026George Simeon · directorM-Exempt30,000$14
Oct 15, 2026KASINGER JAMES R. · officer: General Counsel and SecretaryM-Exempt2,113$0.00
Oct 15, 2026Kulkarni Samarth · director, officer: Chief Executive OfficerSale4,098$49
Oct 15, 2026KASINGER JAMES R. · officer: General Counsel and SecretarySale1,040$49
Oct 15, 2026Kulkarni Samarth · director, officer: Chief Executive OfficerM-Exempt8,333$0.00
Oct 8, 2026KASINGER JAMES R. · officer: General Counsel and SecretaryM-Exempt1,990$14
Oct 8, 2026KASINGER JAMES R. · officer: General Counsel and SecretarySale1,990$60
Sep 24, 2026KASINGER JAMES R. · officer: General Counsel and SecretarySale10,400$60
Sep 24, 2026KASINGER JAMES R. · officer: General Counsel and SecretaryM-Exempt10,400$14
Sep 21, 2026Behbahani Ali · directorSale13,679$57
Sep 21, 2026Behbahani Ali · directorM-Exempt30,000$14
Jun 9, 2026Mahatme Sandesh · directorA-Award13,000$52
Jun 9, 2026High Katherine A · directorA-Award13,000$52
Jun 9, 2026George Simeon · directorA-Award13,000$52
Jun 9, 2026Morrison Briggs · directorA-Award13,000$52
Jun 9, 2026Rommel Christian · directorA-Award13,000$52
Jun 9, 2026Treco Douglas A · directorA-Award13,000$52
Jun 9, 2026Behbahani Ali · directorA-Award13,000$52
Institutional positioning

13F filings over the trailing two quarters

New 165Increased 332Reduced 273Sold out 55
FilerActionSharesFiled
ARK INVESTMENT MANAGEMENT LLCIncreased11,313,623May 12, 2026
ARK Investment Management LLCReduced9,460,939Aug 14, 2026
BlackRock, Inc.Increased8,348,977Aug 7, 2026
BLACKROCK, INC.Increased7,680,073May 13, 2026
ORBIS ALLAN GRAY LTDIncreased6,106,011May 15, 2026
Orbis Allan Gray LtdReduced5,449,161Aug 14, 2026
Capital World InvestorsIncreased4,749,525Aug 12, 2026
CAPITAL WORLD INVESTORSNew Position4,725,037May 13, 2026
STATE STREET CORPIncreased4,321,666Sep 22, 2026
STATE STREET CORPIncreased3,982,500May 15, 2026
GSK plcUnchanged3,220,627Aug 13, 2026
GSK PLCUnchanged3,220,627May 14, 2026
T. ROWE PRICE INVESTMENT MANAGEMENT, INC.Reduced2,952,595May 15, 2026
GEODE CAPITAL MANAGEMENT, LLCIncreased2,509,915Aug 12, 2026
GEODE CAPITAL MANAGEMENT, LLCIncreased2,377,164May 15, 2026

Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Oct 28, 2026